• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲基化 CpG 结合域蛋白 2 通过表观遗传调控 10 到 11 易位 1 和 miR-200s 抑制肺腺癌的恶性特征。

Methyl-CpG Binding Domain Protein 2 Inhibits the Malignant Characteristic of Lung Adenocarcinoma through the Epigenetic Modulation of 10 to 11 Translocation 1 and miR-200s.

机构信息

Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, People's Republic of China.

Department of Thoracic Surgery, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, People's Republic of China.

出版信息

Am J Pathol. 2019 May;189(5):1065-1076. doi: 10.1016/j.ajpath.2019.01.010. Epub 2019 Feb 5.

DOI:10.1016/j.ajpath.2019.01.010
PMID:30735628
Abstract

It has been reported that disorders of epigenetic modulation play a critical role in carcinogenesis. Methyl-CpG binding domain protein 2 (MBD2) is known to act as an epigenetic modulator in various types of tumors; however, the role of MBD2 in lung adenocarcinoma (LUAD) remains unclear. Herein, we demonstrated the down-regulation of MBD2 in LUAD compared with adjacent nontumor tissues. The down-regulation of MBD2 in LUAD was correlated with metastasis and poor survival. In addition, MBD2 inhibited tumor metastasis by maintaining the expression of the miR-200s, which suppressed the invasive properties of tumors. Also, MBD2 positively correlated with 5-hydroxymethylcytosine content in the promoter of miR-200s. The conventional view is that MBD2 acts as a transcriptional suppressor. However, the data revealed that MBD2 may act as a transcriptional activator by recruiting 10 to 11 translocation 1 (TET1) and forming a chromatin-remodeling complex. The MBD2-TET1 complex locates to the TET1 promoter and removes the methyl residues in this region, thereby activating TET1 transcription. TET1 also acted as a tumor suppressor in LUAD. Taken together, the data demonstrate the correlation between MBD2, miR-200s, and TET1, and tumor suppressive effect of MBD2 through up-regulation of TET1 and the miR-200s.

摘要

据报道,表观遗传修饰失调在癌症发生中起着关键作用。甲基-CpG 结合域蛋白 2(MBD2)已知在各种类型的肿瘤中作为表观遗传调节剂起作用;然而,MBD2 在肺腺癌(LUAD)中的作用尚不清楚。在此,我们证明与相邻非肿瘤组织相比,MBD2 在 LUAD 中下调。MBD2 在 LUAD 中的下调与转移和预后不良相关。此外,MBD2 通过维持 miR-200s 的表达来抑制肿瘤转移,从而抑制肿瘤的侵袭特性。此外,MBD2 与 miR-200s 启动子中的 5-羟甲基胞嘧啶含量呈正相关。传统观点认为 MBD2 作为转录抑制因子起作用。然而,数据显示 MBD2 可能通过招募 10 到 11 易位 1(TET1)并形成染色质重塑复合物来充当转录激活剂。MBD2-TET1 复合物定位于 TET1 启动子并去除该区域中的甲基残基,从而激活 TET1 转录。TET1 也在 LUAD 中作为肿瘤抑制因子起作用。总之,数据表明 MBD2、miR-200s 和 TET1 之间存在相关性,并且 MBD2 通过上调 TET1 和 miR-200s 发挥肿瘤抑制作用。

相似文献

1
Methyl-CpG Binding Domain Protein 2 Inhibits the Malignant Characteristic of Lung Adenocarcinoma through the Epigenetic Modulation of 10 to 11 Translocation 1 and miR-200s.甲基化 CpG 结合域蛋白 2 通过表观遗传调控 10 到 11 易位 1 和 miR-200s 抑制肺腺癌的恶性特征。
Am J Pathol. 2019 May;189(5):1065-1076. doi: 10.1016/j.ajpath.2019.01.010. Epub 2019 Feb 5.
2
MicroRNA-191 regulates endometrial cancer cell growth via TET1-mediated epigenetic modulation of APC.MicroRNA-191 通过 TET1 介导的 APC 的表观遗传调控调节子宫内膜癌细胞生长。
J Biochem. 2020 Jul 1;168(1):7-14. doi: 10.1093/jb/mvaa014.
3
Ten-eleven translocation 1 (TET1) gene is a potential target of miR-21-5p in human colorectal cancer.十一易位蛋白1(TET1)基因是人类结直肠癌中miR-21-5p的潜在靶点。
Surg Oncol. 2018 Mar;27(1):76-81. doi: 10.1016/j.suronc.2017.12.004. Epub 2018 Jan 3.
4
MiR-340-3p-HUS1 axis suppresses proliferation and migration in lung adenocarcinoma cells.miR-340-3p-HUS1 轴抑制肺腺癌细胞的增殖和迁移。
Life Sci. 2021 Jun 1;274:119330. doi: 10.1016/j.lfs.2021.119330. Epub 2021 Mar 9.
5
Epigenetic inactivation of the CpG demethylase TET1 as a DNA methylation feedback loop in human cancers.作为人类癌症中一种DNA甲基化反馈环,CpG去甲基化酶TET1的表观遗传失活
Sci Rep. 2016 May 26;6:26591. doi: 10.1038/srep26591.
6
miR-15b enhances the proliferation and migration of lung adenocarcinoma by targeting BCL2.miR-15b 通过靶向 BCL2 增强肺腺癌的增殖和迁移。
Thorac Cancer. 2020 Jun;11(6):1396-1405. doi: 10.1111/1759-7714.13382. Epub 2020 Mar 27.
7
Methyl-CpG binding protein MBD2 is implicated in methylation-mediated suppression of miR-373 in hilar cholangiocarcinoma.甲基化 CpG 结合蛋白 MBD2 参与了肝门部胆管癌中甲基化介导的 miR-373 抑制。
Oncol Rep. 2011 Feb;25(2):443-51. doi: 10.3892/or.2010.1089. Epub 2010 Dec 9.
8
MicroRNA-494 is a master epigenetic regulator of multiple invasion-suppressor microRNAs by targeting ten eleven translocation 1 in invasive human hepatocellular carcinoma tumors.微小RNA-494是侵袭性人类肝细胞癌肿瘤中多种侵袭抑制性微小RNA的主要表观遗传调节因子,它通过靶向10-11易位甲基胞嘧啶双加氧酶1发挥作用。
Hepatology. 2015 Aug;62(2):466-80. doi: 10.1002/hep.27816. Epub 2015 May 6.
9
CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.LNCaP和Tramp - C1前列腺癌细胞系中14 - 3 - 3σ基因表达的CpG岛启动子甲基化和沉默与甲基化CpG结合蛋白MBD2相关。
Oncogene. 2006 Aug 3;25(33):4559-72. doi: 10.1038/sj.onc.1209462. Epub 2006 Jun 19.
10
Circular RNA cMras inhibits lung adenocarcinoma progression via modulating miR-567/PTPRG regulatory pathway.环状 RNA cMras 通过调节 miR-567/PTPRG 调控通路抑制肺腺癌进展。
Cell Prolif. 2019 May;52(3):e12610. doi: 10.1111/cpr.12610. Epub 2019 Apr 22.

引用本文的文献

1
TET1: The epigenetic architect of clinical disease progression.TET1:临床疾病进展的表观遗传构建者。
Genes Dis. 2025 Jan 4;12(5):101513. doi: 10.1016/j.gendis.2025.101513. eCollection 2025 Sep.
2
Targeting Regulatory Noncoding RNAs in Human Cancer: The State of the Art in Clinical Trials.靶向人类癌症中的调控性非编码RNA:临床试验的现状
Pharmaceutics. 2025 Apr 4;17(4):471. doi: 10.3390/pharmaceutics17040471.
3
Knockdown of Methylation-Related Gene MBD2 Blocks Cell Growth by Upregulating p21 Expression in Head and Neck Squamous Cell Carcinoma.
敲低甲基化相关基因MBD2通过上调头颈部鳞状细胞癌中p21的表达来阻断细胞生长。
Cancer Rep (Hoboken). 2024 Dec;7(12):e70080. doi: 10.1002/cnr2.70080.
4
Arsenic disulfide promoted the demethylation of in diffuse large B cell lymphoma cells.二硫化二砷促进弥漫性大 B 细胞淋巴瘤细胞中 的去甲基化。
PeerJ. 2024 May 14;12:e17363. doi: 10.7717/peerj.17363. eCollection 2024.
5
Crosstalk between miRNAs and DNA Methylation in Cancer.miRNAs 与癌症中 DNA 甲基化的相互作用。
Genes (Basel). 2023 May 12;14(5):1075. doi: 10.3390/genes14051075.
6
MBD2 facilitates tumor metastasis by mitigating DDB2 expression.MBD2 通过减轻 DDB2 的表达促进肿瘤转移。
Cell Death Dis. 2023 May 4;14(5):303. doi: 10.1038/s41419-023-05804-1.
7
The long non-coding RNA rhabdomyosarcoma 2-associated transcript exerts anti-tumor effects on lung adenocarcinoma via ubiquitination of .长链非编码RNA横纹肌肉瘤2相关转录本通过……的泛素化对肺腺癌发挥抗肿瘤作用。 (原文此处不完整)
Ann Transl Med. 2022 Jan;10(1):10. doi: 10.21037/atm-21-6052.
8
Epigenetic Regulation of Angiogenesis in Development and Tumors Progression: Potential Implications for Cancer Treatment.发育和肿瘤进展过程中血管生成的表观遗传调控:对癌症治疗的潜在影响
Front Cell Dev Biol. 2021 Sep 6;9:689962. doi: 10.3389/fcell.2021.689962. eCollection 2021.
9
Prognostic role of high TET1 expression in patients with solid tumors: A meta-analysis.高TET1表达在实体瘤患者中的预后作用:一项荟萃分析。
Medicine (Baltimore). 2020 Oct 30;99(44):e22863. doi: 10.1097/MD.0000000000022863.
10
Expression and clinical significance of methyl-CpG binding domain protein 2 in high-grade serous ovarian cancer.甲基化CpG结合域蛋白2在高级别浆液性卵巢癌中的表达及临床意义
Oncol Lett. 2020 Sep;20(3):2749-2756. doi: 10.3892/ol.2020.11836. Epub 2020 Jul 9.